Jack D. Bui - Concepedia

Author

Jack D. Bui

University of California San Diego ORCID

Also Known As

J. Bui, J.D. Bui, Jack Bui, Jack D Bui, Jack D. Bui, Jack D. Bui, Jacqueline P Bui, Jeffrey Borgia, Victor Nizet

215

Publications

7.5K

Citations

H-Index

109

Concepts

All Affiliations

University of California San Diego Washington University in St. Louis Memorial Sloan Kettering Cancer Center Stanford University

About

Jack D. Bui is an author at University of California San Diego specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	28	3.9K
2	Engineering	2	2	289
3	Natural Sciences	2	2	210
4	Public Health	1	1	33
5	Allergy	1	1	33

Jack D. Bui

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers Ayuko Hoshino, Han Sang Kim, Linda Bojmar, Cell Tumor BiologyExtracellular VesicleMedicinePathologyExtracellular Microvesicles	2020	1.2K
A critical function for type I interferons in cancer immunoediting Gavin P. Dunn, Allen T. Bruce, Kathleen C. F. Sheehan, Nature Immunology Cancer ImmunosurveillanceImmunologyTumor ImmunityPathologyImmunologic Mechanism	2005	593
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways Yunlong Zhao, Calvin K. Lee, Chia‐Hao Lin, Immunity Signal TransductionCd80 Cis-heterodimer TriggersImmunologyReceptor (Biochemistry)Co-stimulatory Receptor Cd28	2019	375
Cancer immunoediting by the innate immune system in the absence of adaptive immunity Timothy E. O’Sullivan, Robert Saddawi‐Konefka, William Vermi, The Journal of Experimental Medicine	2012	327
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors Baharak Bahmani, Hua Gong, Brian T. Luk, Nature Communications	2021	285
Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses Brigid S. Boland, Zhaoren He, Matthew Tsai, Science Immunology	2020	264
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer Heinz Läubli, Oliver M.T. Pearce, Flavio Schwarz, Proceedings of the National Academy of Sciences	2014	225
ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness Nancy P. Judd, Ashley E. Winkler, Oihana Murillo, Cancer Research Erk1/2 RegulationOncologyCd44 ExpressionMedicineImmunology	2011	224
Production of unique immunotoxin cancer therapeutics in algal chloroplasts Miller Tran, Christina Van, Daniel J. Barrera, Proceedings of the National Academy of Sciences BiosynthesisBioorganic ChemistryDimeric Immunotoxin ProteinsDimeric ImmunotoxinsEngineering	2012	182
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC Robert Saddawi‐Konefka, Aoife O’Farrell, Farhoud Faraji, Nature Communications	2022	152

Page 1